Hot Topic Discussion: Peter Marks, MD, PhD, Speaks to AABB Community on FDA's..

When:  Feb 2, 2023 from 02:00 PM to 03:00 PM (ET)
Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER), will discuss the FDA’s Jan. 27 draft guidance, "Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products” and its implications for the blood community.

Learn More
Event Image